Immunocore Holdings plc (FRA:6YG)
25.00
-0.80 (-3.10%)
At close: Mar 27, 2026
Immunocore Holdings Revenue
In the year 2025, Immunocore Holdings had annual revenue of $400.02M USD with 28.95% growth. Immunocore Holdings had revenue of $104.48M in the quarter ending December 31, 2025, with 24.30% growth.
Revenue
$400.02M
Revenue Growth
+28.95%
P/S Ratio
3.80
Revenue / Employee
$763.39K
Employees
524
Market Cap
1.30B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 400.02M | 89.81M | 28.95% |
| Dec 31, 2024 | 310.20M | 60.77M | 24.37% |
| Dec 31, 2023 | 249.43M | 75.07M | 43.05% |
| Dec 31, 2022 | 174.36M | 137.88M | 377.91% |
| Dec 31, 2021 | 36.48M | -4.63M | -11.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest Aktiengesellschaft | 635.20M |
| 2invest AG | 28.07M |
| Darwin AG | 27.35M |
| Paion AG | 14.81M |
| co.don AG | 6.24M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| bioXXmed AG | 20.49K |